Literature DB >> 20827762

Low prevalence of hepatitis E infection among pregnant women in Madrid, Spain.

Maria Luisa Mateos Lindemann1, Gustavo Gabilondo, Beatriz Romero, Oihane Martín S de la Maza, Maria Teresa Pérez-Gracia.   

Abstract

Hepatitis E virus, a cause of sporadic hepatitis in developed countries is present in Spain. The aims of this study were to determine whether the prevalence of IgG anti-hepatitis E virus antibodies has increased in recent years in Spain and the prevalence in a study population at risk of developing the disease following the infection. Serum samples from 1,040 women in the first trimester of pregnancy were studied. The prevalence rate of 3.6% has not increased significantly since 1999 in spite of the large number of immigrants from endemic regions. IgM anti-HEV antibodies were detected in 0.67% of the patients suggesting that although subclinical infection exists the prevalence is very low. The reasons for the differences in the morbidity of HEV in pregnant women in different geographical areas remain unclear. Good hygienic measures and public health conditions are important factors for ensuring low prevalence of hepatitis E in Spain.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20827762     DOI: 10.1002/jmv.21840

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  17 in total

1.  Hepatitis E: are psychiatric patients on special risk?

Authors:  Claudia Reinheimer; Regina Allwinn; Annemarie Berger
Journal:  Med Microbiol Immunol       Date:  2011-10-18       Impact factor: 3.402

Review 2.  Hepatitis e and acute liver failure in pregnancy.

Authors:  Subrat K Acharya
Journal:  J Clin Exp Hepatol       Date:  2013-09-05

3.  RNA interference induces effective inhibition of mRNA accumulation and protein expression of SHEV ORF3 gene in vitro.

Authors:  Tao Liu; Ming Lei; Hanwei Jiao; Li Du; Ying Cheng; Donglin Zhang; Yongchang Hao; Churiga Man; Fengyang Wang
Journal:  Curr Microbiol       Date:  2011-01-12       Impact factor: 2.188

4.  A Study of Hepatitis E in Pregnancy: Maternal and Fetal Outcome.

Authors:  Gowri Sayi Prasad; Sayi Prasad; Ashok Bhupali; Ajit N Patil; Kanishtha Parashar
Journal:  J Obstet Gynaecol India       Date:  2015-08-22

5.  Identification of miR-221 and -222 as important regulators in genotype IV swine hepatitis E virus ORF3-expressing HEK 293 cells.

Authors:  Ying Cheng; Li Du; Qiaoyun Shi; Hanwei Jiao; Xiaoru Zhang; Yongchang Hao; Hui Rong; Jianing Zhang; Xiaoxiao Jia; Shiyu Guo; Wenhua Kuang; Hui Zhang; Chuangfu Chen; Fengyang Wang
Journal:  Virus Genes       Date:  2013-04-12       Impact factor: 2.332

6.  Prospective study of Hepatitis E Virus infection among pregnant women in France.

Authors:  Christophe Renou; Vincent Gobert; Christophe Locher; Abdelouahab Moumen; Oumar Timbely; Janine Savary; Anne-Marie Roque-Afonso
Journal:  Virol J       Date:  2014-04-09       Impact factor: 4.099

7.  Seroprevalence of Hepatitis A and Hepatitis E Viruses among Pregnant Women in Northern Iran.

Authors:  Farzin Sadeghi; Zahra Golchob; Maryam Javadian; Mohammad Barary; Parisa Sabbagh; Soheil Ebrahimpour; Masomeh Bayani
Journal:  Infect Dis Obstet Gynecol       Date:  2021-07-02

8.  Seroprevalence of hepatitis e among pregnant women in urmia, iran.

Authors:  Zakieh Rostamzadeh Khameneh; Nariman Sepehrvand; Hamid-Reza Khalkhali
Journal:  Hepat Mon       Date:  2013-11-15       Impact factor: 0.660

9.  Hepatitis E virus seroprevalence in pregnant women in Jiangsu, China, and postpartum evolution during six years.

Authors:  Guangyu Gu; Hongyu Huang; Le Zhang; Yongchun Bi; Yali Hu; Yi-Hua Zhou
Journal:  BMC Infect Dis       Date:  2015-12-09       Impact factor: 3.090

10.  Prevalence and clinical correlation of hepatitis E virus antibody in the patients' serum samples from a tertiary care hospital in Thailand during 2015-2018.

Authors:  Atiporn Boonyai; Anchalee Thongput; Thidarat Sisaeng; Parisut Phumchan; Navin Horthongkham; Wannee Kantakamalakul; Chutikarn Chaimayo
Journal:  Virol J       Date:  2021-07-12       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.